Saurav Shah

Risk-stratified versus standard-duration dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and critical appraisal of prospective evidence

Guidelines endorse risk-stratification tools (DAPT score, PRECISE-DAPT, ARC-HBR) to individualise dual antiplatelet therapy(DAPT) duration after PCI, yet a fixed 12-month course still imposes a uniform ischaemic-bleeding trade-off on a heterogeneous population. To our knowledge,...